Diseases & Conditions

From acute infections to chronic and rare diseases—risk factors, management, and breakthroughs.

  • 5 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Diseases & Conditions

Infectious Diseases Respiratory, GI, vector‑borne, and antimicrobial resistance trends and care. Chronic Diseases Long‑term conditions: heart, lung, metabolic, kidney, and autoimmune care models. Rare Diseases & Genetics Orphan conditions, registries, gene testing, and family support networks. Pain Management Chronic pain, multimodal strategies, interventional options, and safety concerns. Palliative & Hospice Care Symptom relief, goals of care, and quality of life in serious illness.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Diseases & Conditions


ccxmedia.org > news > newsmakers-michelle-perdues-one-woman-show-takes-aim-at-breast-cancer

Newsmakers: Michelle Perdue's One-Woman Show Takes Aim at Breast Cancer

3+ hour, 1+ min ago   (248+ words) For Michelle Perdue, Jan. 17, 2017, was the day that changed her life. It was the day she learned she had breast cancer. Fast forward to today, she has not only survived but thrived. Perdue is the writer and sole actor in…...


texasborderbusiness.com > mcallen-cancer-survivor-heads-to-washington-to-urge-congress-to-make-cancer-a-national-priority

McAllen Cancer Survivor Heads to Washington to Urge Congress to Make Cancer a National Priority

3+ hour, 30+ min ago   (450+ words) Elvia Gibbs will join more than 700 advocates calling for stronger research funding and improved access to cancer clinical trials McALLEN, Texas — McAllen resident and cancer survivor Elvia Gibbs will travel to Washington, D.C., to join hundreds of cancer patients, survivors…...


navlindaily.com > article > 31862 > association-calls-for-compassionate-access-to-daraxonrasib-in-italy

NAVLIN DAILY

12+ hour, 7+ min ago   (11+ words) Association Calls for Compassionate Access to Daraxonrasib in Italy NAVLIN DAILY...


ataraxis.ai > causal-ai-chemotherapy-benefit

Causal multi-modal AI predicts who benefits from chemotherapy — and who will not

5+ hour, 25+ min ago   (510+ words) Authors: Dhruva Biswas and Krzysztof J. Geras AI-enabled perception of how treatment choice shapes patient trajectories. Causal multi-modal AI turns routine pathology and clinical data into personalized estimates of chemosensitivity, separating risk of recurrence from treatment benefit to help direct chemotherapy…...


openpr.com > news > 4631015 > follicular-lymphoma-market-to-expand-rapidly-with-advancing

Follicular Lymphoma Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 - DelveInsight

1+ hour, 45+ min ago   (62+ words) Follicular Lymphoma Market to Expand Rapidly with Advancing openpr.com Follicular Lymphoma Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 - DelveInsight Press release from: DelveInsight Business Research Permanent link to this press release: You can edit…...


securities.io > evicore-to-cover-guardant-health-shield-colorectal-cancer-blood-test

EviCore to Cover Guardant Health Shield Colorectal Cancer Blood Test

13+ min ago   (282+ words) Guardant said the EviCore update extends rapid growth in commercial adoption over its last fiscal quarter, following what it called meaningful coverage expansion from Carelon, which it described as the largest specialty benefits manager in the United States, and UnitedHealth…...


hsph.harvard.edu > epidemiology > news > qa-with-alumnus-julie-buring

Q&A with Julie Buring | Harvard T.H. Chan School of Public Health

2+ hour, 9+ min ago   (300+ words) Q&A with Julie Buring hsph.harvard.edu Your gift powers excellence in research and education to advance public health. Q&A with Julie Buring Julie Elizabeth Buring, ScD ’83, has devoted her career to the prevention of chronic disease, particularly…...


buglenewspapers.com > story > 09/14/2026 > lifestyles > illinois-students-raise-awareness-of-deadly-radon-gas-through-award-winning-creations > 2222.html

Illinois Students Raise Awareness of Deadly Radon Gas Through Award-Winning Creations

3+ hour, 34+ min ago   (126+ words) buglenewspapers.com Illinois Students Raise Awareness of Deadly Radon Gas Through Award-Winning Creations Students win monetary prizes for educating communities about radon, a dangerous, invisible gas found in Illinois homes and schools. CHICAGO – (July 14, 2026) – Local students are being recognized for…...


buffalonews.com > news > nation-world > article_1eec3004-8a2c-4341-9edc-5c330eb05b9b.html

Why mRNA vaccines are giving cancer patients hope

45+ min ago   (187+ words) Buffalo News Javascript is required to use this website. Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead. This story was originally published by PolitiFact. People…...


tradingview.com > news > urn:summary_document_transcript:quartr.com:4167979:0-zntl-azenosertib-nears-pivotal-data-in-ovarian-cancer-with-fda-backing-and-robust-financial-runway

ZNTL: Azenosertib nears pivotal data in ovarian cancer, with FDA backing and robust financial runway

55+ min ago   (77+ words) TradingView Azenosertib is advancing in late-stage trials for platinum-resistant ovarian cancer, with strong FDA support and a differentiated safety profile. Expansion into earlier lines and other tumor types is under evaluation, while commercial and financial preparations ensure readiness for upcoming…...